MAK Capital One
Overview
MAK Capital One is a private investment firm with a focus on distressed debt, high-yield, and special situation investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Trailhead Biosystems Inc. | Jan 2026 | Extension | Lead |
| C-Motive Technologies | Jul 2025 | VC Round | Lead |
| Noveome Biotherapeutics | Apr 2025 | Series E | Lead |
| MARAbio | Oct 2024 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is MAK Capital One based?
MAK Capital One is headquartered in New York City, New York, United States.
When was MAK Capital One founded?
MAK Capital One was founded in 2005.
How many portfolio companies does MAK Capital One have?
MAK Capital One has 4 portfolio companies in Caplight's dataset.
What are some companies in MAK Capital One's portfolio?
Portfolio companies visible on Caplight include Trailhead Biosystems Inc., C-Motive Technologies, Noveome Biotherapeutics, MARAbio.
What was MAK Capital One's most recent investment shown here?
MAK Capital One's most recent investment in this portfolio sample was in Trailhead Biosystems Inc. in 2026.
What sectors does MAK Capital One focus on?
MAK Capital One focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability.
What company stages does MAK Capital One focus on?
Stage focus information for MAK Capital One is not publicly available.
What is MAK Capital One's AUM?
MAK Capital One's assets under management are estimated between $1.7B and $1.7B.